Another potential therapeutic target proposed for the treatment of COPD is the aryl hydrocarbon receptor repressor (AHRR), a repressor of aryl hydrocarbon receptor (AHR), which regulated the xenobiotic metabolism and the apoptotic processes [20,64]. Here, AHR is linked to chronic obstructive pulmonary disease.